• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定乳腺癌 LCK 原癌基因作为三阴性乳腺癌中性粒细胞富集和极化的主要调节因子。

Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization.

机构信息

Department of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.

出版信息

Int J Mol Sci. 2023 Aug 26;24(17):13269. doi: 10.3390/ijms241713269.

DOI:10.3390/ijms241713269
PMID:37686072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10487917/
Abstract

The role of neutrophils in breast cancer shows that the N1 proinflammatory subtype can suppress and attack the tumor. In contrast, the N2 pro-tumor subtype aids the tumor in its survival, progression, and metastasis. Recently, more focus has been directed to the role of innate myeloid cells, specifically neutrophils, in regulating the responses of lymphoid populations both in the progression of cancer and in response to therapy. However, the exact crosstalk between breast cancer cells and neutrophils is poorly understood. In this work, we used in-silico assays to investigate the role of the bidirectional effect of neutrophils on metastatic TNBC. Our reanalysis of publicly available data reveals that most TNBC's classified within the CE2 subtype are leukocyte-poor and have four major cell types in their ecotypes: dendritic cells, macrophages, fibroblasts, and epithelial cells. Further immune deconvolution of these patients revealed that a few cells significantly differed between groups, including macrophages, neutrophils, and T cells. All BC showed lower infiltrating neutrophils compared to healthy surrounding tissue. Treated TNBCs improved the count of infiltrating neutrophils in TNBC. Most TNBC patients have a unique CE2 ecotype, characterized by more basal-like epithelial cells, more neutrophils, and fewer mononuclear lymphocytes (B cells, macrophages M1, T cell CD4+ (non-regulatory), and T cell CD8+ and T regs). This can be related to our finding that CE2 TNBCs are characterized by a lower LCK and higher ERBB2, and their top DEGs are related to leukocyte activation and NFKB pathway.

摘要

中性粒细胞在乳腺癌中的作用表明,N1 促炎亚型可以抑制和攻击肿瘤。相比之下,N2 促肿瘤亚型有助于肿瘤的存活、进展和转移。最近,更多的注意力集中在固有髓样细胞(特别是中性粒细胞)在调节淋巴样细胞群对癌症进展和治疗反应的作用上。然而,乳腺癌细胞与中性粒细胞之间的确切串扰仍知之甚少。在这项工作中,我们使用了计算机模拟实验来研究中性粒细胞对转移性三阴性乳腺癌的双向作用的作用。我们对公开可用数据的重新分析表明,大多数被归类为 CE2 亚型的三阴性乳腺癌中白细胞较少,其生态型中有四种主要细胞类型:树突状细胞、巨噬细胞、成纤维细胞和上皮细胞。对这些患者的进一步免疫分解表明,少数细胞在组间有显著差异,包括巨噬细胞、中性粒细胞和 T 细胞。所有 BC 显示浸润性中性粒细胞均低于健康周围组织。治疗后的三阴性乳腺癌改善了三阴性乳腺癌中浸润性中性粒细胞的计数。大多数三阴性乳腺癌患者具有独特的 CE2 生态型,其特征是基底样上皮细胞更多,中性粒细胞更多,单核淋巴细胞(B 细胞、巨噬细胞 M1、T 细胞 CD4+(非调节性)和 T 细胞 CD8+和 Tregs)更少。这可能与我们的发现有关,即 CE2 三阴性乳腺癌的特征是 LCK 较低,ERBB2 较高,其顶级 DEGs 与白细胞激活和 NFKB 途径有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/6a8427e78ca0/ijms-24-13269-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/678b13793be8/ijms-24-13269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/2dce8336bcc3/ijms-24-13269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/c4fe8a080c0c/ijms-24-13269-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/2b7c63df5bfb/ijms-24-13269-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/e0533a1f298d/ijms-24-13269-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/9036413c33d6/ijms-24-13269-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/acac20030a30/ijms-24-13269-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/f6a239aeee6b/ijms-24-13269-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/332acf00253f/ijms-24-13269-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/59101fc1f9a6/ijms-24-13269-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/58db59d1fc20/ijms-24-13269-g011a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/6a8427e78ca0/ijms-24-13269-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/678b13793be8/ijms-24-13269-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/2dce8336bcc3/ijms-24-13269-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/c4fe8a080c0c/ijms-24-13269-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/2b7c63df5bfb/ijms-24-13269-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/e0533a1f298d/ijms-24-13269-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/9036413c33d6/ijms-24-13269-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/acac20030a30/ijms-24-13269-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/f6a239aeee6b/ijms-24-13269-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/332acf00253f/ijms-24-13269-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/59101fc1f9a6/ijms-24-13269-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/58db59d1fc20/ijms-24-13269-g011a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ded/10487917/6a8427e78ca0/ijms-24-13269-g012.jpg

相似文献

1
Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization.鉴定乳腺癌 LCK 原癌基因作为三阴性乳腺癌中性粒细胞富集和极化的主要调节因子。
Int J Mol Sci. 2023 Aug 26;24(17):13269. doi: 10.3390/ijms241713269.
2
MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.MUC1-C 可将 IFN-γ 通路的激活与三阴性乳腺癌肿瘤免疫微环境的抑制相结合。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-002115.
3
Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance.三阴性乳腺癌中的中性粒细胞:一个被低估的角色,其重要性日益得到认可。
Breast Cancer Res. 2023 Jul 26;25(1):88. doi: 10.1186/s13058-023-01676-7.
4
Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.三阴性乳腺癌——免疫相关因素的预后作用:一项系统综述
Acta Oncol. 2018 Jan;57(1):74-82. doi: 10.1080/0284186X.2017.1400180. Epub 2017 Nov 23.
5
EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.EP300 敲低降低三阴性乳腺癌中的癌症干细胞表型、肿瘤生长和转移。
BMC Cancer. 2020 Nov 10;20(1):1076. doi: 10.1186/s12885-020-07573-y.
6
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.基于NanoString技术的免疫相关基因特征在三阴性乳腺癌新辅助治疗中的预后和预测价值:与肿瘤浸润淋巴细胞的关系
Breast Cancer Res Treat. 2015 Jun;151(3):619-27. doi: 10.1007/s10549-015-3438-8. Epub 2015 May 26.
7
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.肿瘤基质中高 CD8 与 FOXP3 的比值和肿瘤细胞中 PTEN 的表达与非转移性三阴性乳腺癌患者的生存改善相关。
BMC Cancer. 2021 Aug 6;21(1):901. doi: 10.1186/s12885-021-08636-4.
8
Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.自噬调节因子BECN1抑制由WNT1激活和产后引起的乳腺肿瘤发生。
Autophagy. 2014;10(11):2036-52. doi: 10.4161/auto.34398. Epub 2014 Oct 30.
9
Role of inflammatory infiltrates in triple negative breast cancer.炎症浸润在三阴性乳腺癌中的作用。
J Clin Pathol. 2015 Jul;68(7):506-10. doi: 10.1136/jclinpath-2015-202944. Epub 2015 Mar 6.
10
The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.趋化因子配体2的阴阳两面:在体外对中性粒细胞抗肿瘤活性作用较小,但在体内对肺转移性乳腺癌病灶的生长起主要作用。
BMC Cancer. 2017 Jan 31;17(1):88. doi: 10.1186/s12885-017-3074-2.

引用本文的文献

1
Neutrophils as key regulators of tumor microenvironment in breast cancer: a focus on N1 and N2 polarization.中性粒细胞作为乳腺癌肿瘤微环境的关键调节因子:聚焦于N1和N2极化
Ann Med Surg (Lond). 2025 Apr 10;87(6):3509-3522. doi: 10.1097/MS9.0000000000003269. eCollection 2025 Jun.
2
The therapeutic effect and targets of on breast cancer and the construction of a prognostic signature consisting of inflammation-related genes.[具体药物名称]对乳腺癌的治疗效果、靶点及由炎症相关基因组成的预后特征构建
Heliyon. 2024 May 11;10(10):e31137. doi: 10.1016/j.heliyon.2024.e31137. eCollection 2024 May 30.

本文引用的文献

1
Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.国家癌症数据库中 ERBB2 低表达乳腺癌患者的临床病理特征和预后。
JAMA Oncol. 2023 Apr 1;9(4):500-510. doi: 10.1001/jamaoncol.2022.7476.
2
The lymphatic endothelium-derived follistatin: activin A axis regulates neutrophil motility in response to Pseudomonas aeruginosa.淋巴内皮细胞衍生的卵泡抑素:激活素 A 轴调节中性粒细胞对铜绿假单胞菌的运动。
Integr Biol (Camb). 2023 Apr 11;15. doi: 10.1093/intbio/zyad003.
3
Immunotherapy in breast cancer: an overview of current strategies and perspectives.
乳腺癌免疫治疗:当前策略与前景综述
NPJ Breast Cancer. 2023 Feb 13;9(1):7. doi: 10.1038/s41523-023-00508-3.
4
Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women.利用公开可用的数据集来识别基于人群的转录组图谱,该图谱有助于了解年轻女性乳腺癌的侵袭性。
Front Genet. 2023 Jan 4;13:1039037. doi: 10.3389/fgene.2022.1039037. eCollection 2022.
5
Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses.细胞毒素:细胞毒性的机制及其对炎症反应的影响。
Cells. 2023 Jan 3;12(1):195. doi: 10.3390/cells12010195.
6
Breast Cancer in the United Arab Emirates.阿拉伯联合酋长国的乳腺癌
JCO Glob Oncol. 2023 Jan;9:e2200247. doi: 10.1200/GO.22.00247.
7
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.曲妥珠单抗辅助治疗 HER2 阳性早期乳腺癌的安全性:一项基于人群的队列研究
ESMO Open. 2023 Feb;8(1):100747. doi: 10.1016/j.esmoop.2022.100747. Epub 2022 Dec 21.
8
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.GSCA:一个用于在基因组、药物基因组学和免疫基因组学水平进行基因集癌症分析的综合平台。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac558.
9
Intratumoral bacteria are an important "accomplice" in tumor development and metastasis.肿瘤内细菌是肿瘤发生发展和转移过程中的重要“帮凶”。
Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188846. doi: 10.1016/j.bbcan.2022.188846. Epub 2022 Dec 8.
10
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities.三阴性乳腺癌的免疫治疗:对肿瘤免疫微环境和治疗机会的见解
Front Mol Biosci. 2022 Aug 19;9:903065. doi: 10.3389/fmolb.2022.903065. eCollection 2022.